# Filing Detail

Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001437749-22-028113
Filing Date
2022-11-28
Accepted
2022-11-28 17:17:57
Documents
6

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | dffn20221127_prer14a.htm | PRER14A | 543357
2 |  | card01.jpg | GRAPHIC | 183622
3 |  | dffn20221117_prec14aimg001.jpg | GRAPHIC | 7826
4 |  | dffn20221117_prec14aimg002.jpg | GRAPHIC | 7339
5 |  | dffn20221117_prec14aimg003.jpg | GRAPHIC | 7339
6 |  | diff01.jpg | GRAPHIC | 383119
| Complete submission text file | 0001437749-22-028113.txt |  | 1356829

Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-37942 | Film No.: 221426868
SIC: 2834 Pharmaceutical Preparations